首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Yakugaku zasshi-journal of the pharmaceutical society of japan

缩写:YAKUGAKU ZASSHI

ISSN:0031-6903

e-ISSN:1347-5231

IF/分区:0.2/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引2796
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Masaaki Kurihara Masaaki Kurihara
We performed the design, synthesis and evaluation of ligands of nuclear receptors [vitamin D receptor (VDR), retinoid receptor and a VDR mutant], stapled short helical peptides as VDR-coactivator interaction inhibitors, and estrogen recepto...
Hayato Fukuda Hayato Fukuda
Resolvins are endogenous polyunsaturated fatty acids that show strong anti-inflammatory activity and are therefore expected to be promising new anti-inflammatory drug candidates. However, resolvins have many problems, including instability....
Momoka Yamaguchi Momoka Yamaguchi
Chronic liver disease causes approximately 2 million deaths annually worldwide, accounting for nearly 4% of global mortality. Liver fibrosis is a central pathological feature driving the progression of chronic liver disease (CLD), irrespect...
Satoru Matsunuma,Harutaka Seshimo,Shigeki Sunaga et al. Satoru Matsunuma et al.
Cutaneous adverse events associated with tirabrutinib have been reported in clinical trials; however, their overall incidence and severity vary, and real-world data remain limited. This study aimed to assess the incidence and management of ...
Nobuaki Sampa,Kengo Ohashi,Yasutaka Shinoda et al. Nobuaki Sampa et al.
Piperacillin/tazobactam (PIPC/TAZ) and vancomycin (VCM) are frequently used in combination (PTV) to manage severe healthcare-associated infections, but are also associated with an increased risk of acute kidney injury (AKI). In 2019, Ogaki ...
Tatsuki Fukami Tatsuki Fukami
Drug-induced liver injury (DILI) remains a major cause of drug withdrawal from the market, and safety concerns in clinical settings. Reactive metabolites, primarily produced by cytochrome P450 enzymes, are known to induce oxidative stress a...
Shigeki Aoki,Akira Kazaoka,Kousei Ito Shigeki Aoki
Idiosyncratic drug-induced liver injury (iDILI) is a rare but serious adverse reaction that occurs only in a small subset of individuals. Traditionally, drug-induced liver injury has been studied primarily through the lens of hepatocellular...
Ryuji Kato Ryuji Kato
Idiosyncratic drug-induced liver injury (IDILI) is particularly problematic due to its severity and unpredictability. Various pathogenic mechanisms have been proposed for IDILI; however, these mechanisms have yet to be comprehensively eluci...
Atsushi Kawase,Hiroaki Shimada,Fuminori Sakurai Atsushi Kawase
Acyl glucuronides (AG), reactive metabolites formed via the glucuronidation of carboxylic acid-containing drugs such as non-steroidal anti-inflammatory drugs (NSAIDs), are closely associated with drug-induced liver injury (DILI), particular...